It appears that at least in NF1-associated MPNSTs, progression from benign to malignant status frequently proceeds through sequential inactivation of three tumor suppressors: NF1, CDKN2A/B, and SUZ12 and/or EED (PRC2 complex). The gene discussed is NF1; the disease is neoplasm.